Research Paper Volume 12, Issue 22 pp 22776—22793

Immune-related biomarker risk score predicts prognosis in prostate cancer

Figure 8. Differences in immune characteristics between the high and low risk score groups. (A) Expression of 75 immunomodulators in the high and low risk groups. “*” indicates a difference in expression between the high and low risk groups. (B) Immune-related GSEA enrichment analysis.